Verastem (LTS:0LOV) Short Percentage of Float


LTS:0LOV Verastem Inc LTS:0LOV
23 GF Score
Price $4.78
GF Value $49.62
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Verastem Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0LOV vs IRD, PALI, GALT: Short Percentage of Float Comparison

For the Biotechnology subindustry, Verastem's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verastem Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Verastem's Short Percentage of Float falls into.


LTS:0LOV
23GF Score
Verastem Inc LTS:0LOV
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Verastem (LTS:0LOV) Overvalued in 2026?

Based on GuruFocus' analysis, Verastem stock appears to be undervalued. The current stock price of $4.78 is trading 90.4% below its estimated GF Value™ of $49.62. GuruFocus considers Verastem to be Possible Value Trap.

Key valuation signals for LTS:0LOV:

  • Short Percentage of Float:
  • GF Value™: $49.62 vs. price of $4.78 (90.4% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the LTS:0LOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Verastem Business Description

Other Exchanges VSTM:USA2VS:Germany
Address 117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
23GF Score

Get the complete analysis for LTS:0LOV

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.78
Price
$49.62
GF Value